argenx SE | ARGX - Current Assets

Stock Price
693.20
Daily Change
-1.00 -0.14%
Monthly
-2.45%
Yearly
37.43%
Q2 Forecast
678.23

argenx SE reported $6.9B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
AstraZeneca USD 29.61B 890M Mar/2026
Genmab DKK 2.88B 1.59B Dec/2025
GlaxoSmithKline GBP 17.76B 251M Mar/2026
GRIFOLS EUR 5.25B 180M Mar/2026
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Lakefront Biotherapeutics EUR 3.06B 18.72M Mar/2026
Qiagen NV USD 2B 535.87M Dec/2025
UCB EUR 6.05B 733M Dec/2025